Advertisement

European Archives of Oto-Rhino-Laryngology

, Volume 276, Issue 12, pp 3495–3505 | Cite as

EORTC Quality of Life Questionnaire Head and Neck (H&N)-35 scores from H&N squamous cell carcinoma patients obtained at diagnosis and at 6, 9 and 12 months following diagnosis predict 10-year overall survival

  • Hans Jørgen AarstadEmail author
  • Arild Andrè Østhus
  • Helene Hersvik Aarstad
  • Stein Lybak
  • Anne Kari H. Aarstad
Head and Neck

Abstract

Purpose

To study the 10-year overall survival predictions, and mechanisms behind, of head and neck (HN) quality of life (QoL) scores obtained at diagnosis and 6, 9, and 12 months following diagnosis in a cohort of HN squamous cell carcinoma (HNSCC) patients.

Methods

Consecutive HNSCC patients (N = 109) subjected to standard workup and treatment self-reported their QoL measured by the EORTC Quality of Life Questionnaire (QLQ) H&N-35 between November 2002 and June 2005. Each QoL index was calculated and additionally aggregated to one sum score. The included patients were at diagnosis younger than 78 years, judged adequately cognitive functioning, and scheduled for curative treatment. Self-reported smoking, alcohol consumption, and socio-demographic information were registered. Twenty-two patients were high-risk (hr)-HPV DNA tumor positive. If the treatment goal was changed to palliative, no new QoL information was collected. All living patients were followed until 10 years after diagnosis.

Results

Median survival was 105 months. Significant overall survival predictions were found from the EORTC H&N-35 QLQ sum scores continuously measured at diagnosis (p = 0.006) and obtained at 6 (p = 0.02), 9 (p = 0.002) and 12 (p = 0.05) months. Lower QoL predicted lower overall survival. These sum score survival predictions were in part independent of TNM stage, hr-HPV status, gender, age, alcohol and smoking status. The indices “pain”, “swallowing”, “social eating”, and “feeling ill” were predictive of survival at 3 out of 4 measuring points (diagnosis, 6, 9 and 12 months) in univariate analyses.

Conclusion

EORTC H&N-35 QLQ scores at diagnosis and throughout the first year thereafter harbor prognostic power.

Keywords

Head and neck neoplasms Quality of life Prognosis Human papilloma virus 

Notes

Funding

This work has been supported by the Norwegian Cancer Society.

Compliance with ethical standards

Conflict of interest

All authors declare no conflict of interest.

Ethical approval

This article does not contain any studies with animals performed by the authors. The study was conducted in accordance with the guidelines of the Declaration of Helsinki and its subsequent amendments and was approved by the institutional review board according to national regulations.

Informed consent

A written, informed consent was obtained from all participants of the study.

References

  1. 1.
    Sherman AC, Simonton S (2010) Advances in quality of life research among head and neck cancer patients. Curr Oncol Rep 12(3):208–215.  https://doi.org/10.1007/s11912-010-0092-5 CrossRefPubMedGoogle Scholar
  2. 2.
    Klein J, Livergant J, Ringash J (2014) Health related quality of life in head and neck cancer treated with radiation therapy with or without chemotherapy: a systematic review. Oral Oncol 50(4):254–262.  https://doi.org/10.1016/j.oraloncology.2014.01.015 CrossRefPubMedGoogle Scholar
  3. 3.
    Verdonck-de Leeuw IM, van Nieuwenhuizen A, Leemans CR (2012) The value of quality-of-life questionnaires in head and neck cancer. Curr Opin Otolaryngol Head Neck Surg 20(2):142–147.  https://doi.org/10.1097/MOO.0b013e32834f5fd7 CrossRefPubMedGoogle Scholar
  4. 4.
    van Nieuwenhuizen AJ, Buffart LM, Brug J, Leemans CR, Verdonck-de Leeuw IM (2015) The association between health related quality of life and survival in patients with head and neck cancer: a systematic review. Oral Oncol 51(1):1–11.  https://doi.org/10.1016/j.oraloncology.2014.09.002 CrossRefPubMedGoogle Scholar
  5. 5.
    Montazeri A (2009) Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008. Health Qual Life Outcomes 7:102.  https://doi.org/10.1186/1477-7525-7-102 CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Osthus AA, Aarstad AK, Olofsson J, Aarstad HJ (2013) Prediction of survival by pretreatment health-related quality-of-life scores in a prospective cohort of patients with head and neck squamous cell carcinoma. JAMA Otolaryngol Head Neck Surg 139(1):14–20.  https://doi.org/10.1001/jamaoto.2013.1056 CrossRefPubMedGoogle Scholar
  7. 7.
    Forman D, de Martel C, Lacey CJ, Soerjomataram I, Lortet-Tieulent J, Bruni L, Vignat J, Ferlay J, Bray F, Plummer M, Franceschi S (2012) Global burden of human papillomavirus and related diseases. Vaccine 30(Suppl 5):F12–23.  https://doi.org/10.1016/j.vaccine.2012.07.055 CrossRefPubMedGoogle Scholar
  8. 8.
    Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tan PF, Westra WH, Chung CH, Jordan RC, Lu C, Kim H, Axelrod R, Silverman CC, Redmond KP, Gillison ML (2010) Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363(1):24–35.  https://doi.org/10.1056/NEJMoa0912217 CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Ljokjel B, Lybak S, Haave H, Olofsson J, Vintermyr OK, Aarstad HJ (2014) The impact of HPV infection on survival in a geographically defined cohort of oropharynx squamous cell carcinoma (OPSCC) patients in whom surgical treatment has been one main treatment. Acta Otolaryngol 134(6):636–645.  https://doi.org/10.3109/00016489.2014.886336 CrossRefPubMedGoogle Scholar
  10. 10.
    Sobin LH, Wittekind C, International Union Against C (2002) TNM: classification of malignant tumours, 6th edn. Wiley, New YorkGoogle Scholar
  11. 11.
    Bjordal K, Ahlner-Elmqvist M, Tollesson E, Jensen AB, Razavi D, Maher EJ, Kaasa S (1994) Development of a European Organization for Research and Treatment of Cancer (EORTC) questionnaire module to be used in quality of life assessments in head and neck cancer patients. EORTC Quality of Life Study Group. Acta Oncol 33(8):879–885CrossRefGoogle Scholar
  12. 12.
    Piccirillo JF, Tierney RM, Costas I, Grove L, Spitznagel EL Jr (2004) Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA 291(20):2441–2447.  https://doi.org/10.1001/jama.291.20.2441 CrossRefPubMedGoogle Scholar
  13. 13.
    Ojesina AI, Lichtenstein L, Freeman SS, Pedamallu CS, Imaz-Rosshandler I, Pugh TJ, Cherniack AD, Ambrogio L, Cibulskis K, Bertelsen B, Romero-Cordoba S, Trevino V, Vazquez-Santillan K, Guadarrama AS, Wright AA, Rosenberg MW, Duke F, Kaplan B, Wang R, Nickerson E, Walline HM, Lawrence MS, Stewart C, Carter SL, McKenna A, Rodriguez-Sanchez IP, Espinosa-Castilla M, Woie K, Bjorge L, Wik E, Halle MK, Hoivik EA, Krakstad C, Gabino NB, Gomez-Macias GS, Valdez-Chapa LD, Garza-Rodriguez ML, Maytorena G, Vazquez J, Rodea C, Cravioto A, Cortes ML, Greulich H, Crum CP, Neuberg DS, Hidalgo-Miranda A, Escareno CR, Akslen LA, Carey TE, Vintermyr OK, Gabriel SB, Barrera-Saldana HA, Melendez-Zajgla J, Getz G, Salvesen HB, Meyerson M (2014) Landscape of genomic alterations in cervical carcinomas. Nature 506(7488):371–375.  https://doi.org/10.1038/nature12881 CrossRefPubMedGoogle Scholar
  14. 14.
    Aarstad HJ, Vintermyr OK, Ulvestad E, Aarstad HH, Kross KW, Heimdal JH (2015) Peripheral blood monocyte and T lymphocyte activation levels at diagnosis predict long term survival in head and neck squamous cell carcinoma patients. APMIS 123(4):305–314.  https://doi.org/10.1111/apm.12356 CrossRefPubMedGoogle Scholar
  15. 15.
    Aarstad HJ, Osthus AA, Aarstad HH, Lybak S, Aarstad AKH (2018) General health-related quality of life scores from head and neck squamous cell carcinoma patients obtained throughout the first year following diagnosis predicted up to 10-year overall survival. Eur Arch Otorhinolaryngol 275(1):207–217.  https://doi.org/10.1007/s00405-017-4800-8 CrossRefPubMedGoogle Scholar
  16. 16.
    Osthus AA, Aarstad AK, Olofsson J, Aarstad HJ (2011) Head and neck specific health related quality of life scores predict subsequent survival in successfully treated head and neck cancer patients: a prospective cohort study. Oral Oncol 47(10):974–979.  https://doi.org/10.1016/j.oraloncology.2011.07.010 CrossRefPubMedGoogle Scholar
  17. 17.
    Osthus AA, Aarstad AK, Olofsson J, Aarstad HJ (2011) Health-related quality of life scores in long-term head and neck cancer survivors predict subsequent survival: a prospective cohort study. Clin Otolaryngol 36(4):361–368.  https://doi.org/10.1111/j.1749-4486.2011.02342.x CrossRefPubMedGoogle Scholar
  18. 18.
    Grignon LM, Jameson MJ, Karnell LH, Christensen AJ, Funk GF (2007) General health measures and long-term survival in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 133(5):471–476.  https://doi.org/10.1001/archotol.133.5.471 CrossRefPubMedGoogle Scholar
  19. 19.
    Siddiqui F, Pajak TF, Watkins-Bruner D, Konski AA, Coyne JC, Gwede CK, Garden AS, Spencer SA, Jones C, Movsas B (2008) Pretreatment quality of life predicts for locoregional control in head and neck cancer patients: a radiation therapy oncology group analysis. Int J Radiat Oncol Biol Phys 70(2):353–360.  https://doi.org/10.1016/j.ijrobp.2007.06.024 CrossRefPubMedGoogle Scholar
  20. 20.
    Mehanna HM, Morton RP (2006) Does quality of life predict long-term survival in patients with head and neck cancer? Arch Otolaryngol Head Neck Surg 132(1):27–31.  https://doi.org/10.1001/archotol.132.1.27 CrossRefPubMedGoogle Scholar
  21. 21.
    Urba S, Gatz J, Shen W, Hossain A, Winfree K, Koustenis A, Peterson P, Cohen EE (2012) Quality of life scores as prognostic factors of overall survival in advanced head and neck cancer: analysis of a phase III randomized trial of pemetrexed plus cisplatin versus cisplatin monotherapy. Oral Oncol 48(8):723–729.  https://doi.org/10.1016/j.oraloncology.2012.02.016 CrossRefPubMedGoogle Scholar
  22. 22.
    Tarsitano A, Pizzigallo A, Ballone E, Marchetti C (2012) Health-related quality of life as a survival predictor for patients with oral cancer: is quality of life associated with long-term overall survival? Oral Surg Oral Med Oral Pathol Oral Radiol 114(6):756–763.  https://doi.org/10.1016/j.oooo.2012.06.022 CrossRefPubMedGoogle Scholar
  23. 23.
    Tsai WL, Chien CY, Huang HY, Liao KC, Fang FM (2013) Prognostic value of quality of life measured after treatment on subsequent survival in patients with nasopharyngeal carcinoma. Qual Life Res 22(4):715–723.  https://doi.org/10.1007/s11136-012-0213-8 CrossRefPubMedGoogle Scholar
  24. 24.
    Carrillo JF, Carrillo LC, Ramirez-Ortega MC, Ochoa-Carrillo FJ, Onate-Ocana LF (2016) The impact of treatment on quality of life of patients with head and neck cancer and its association with prognosis. Eur J Surg Oncol 42(10):1614–1621.  https://doi.org/10.1016/j.ejso.2016.05.037 CrossRefPubMedGoogle Scholar
  25. 25.
    Beisland E, Aarstad AK, Osthus AA, Aarstad HJ (2013) Stability of distress and health-related quality of life as well as relation to neuroticism, coping and TNM stage in head and neck cancer patients during follow-up. Acta Otolaryngol 133(2):209–217.  https://doi.org/10.3109/00016489.2012.720032 CrossRefPubMedGoogle Scholar
  26. 26.
    Young D, Xiao CC, Murphy B, Moore M, Fakhry C, Day TA (2015) Increase in head and neck cancer in younger patients due to human papillomavirus (HPV). Oral Oncol 51(8):727–730.  https://doi.org/10.1016/j.oraloncology.2015.03.015 CrossRefPubMedGoogle Scholar
  27. 27.
    Quinten C, Martinelli F, Coens C, Sprangers MA, Ringash J, Gotay C, Bjordal K, Greimel E, Reeve BB, Maringwa J, Ediebah DE, Zikos E, King MT, Osoba D, Taphoorn MJ, Flechtner H, Schmucker-Von Koch J, Weis J, Bottomley A (2014) A global analysis of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different tumor sites. Cancer 120(2):302–311.  https://doi.org/10.1002/cncr.28382 CrossRefPubMedGoogle Scholar
  28. 28.
    Osthus AA, Aarstad AK, Olofsson J, Aarstad HJ (2013) Comorbidity is an independent predictor of health-related quality of life in a longitudinal cohort of head and neck cancer patients. Eur Arch Otorhinolaryngol 270(5):1721–1728.  https://doi.org/10.1007/s00405-012-2207-0 CrossRefPubMedGoogle Scholar
  29. 29.
    Huang SH, O'Sullivan B (2017) Overview of the 8th edition TNM classification for head and neck cancer. Curr Treat Opt Oncol 18(7):40.  https://doi.org/10.1007/s11864-017-0484-y CrossRefGoogle Scholar
  30. 30.
    Zylla D, Steele G, Gupta P (2017) A systematic review of the impact of pain on overall survival in patients with cancer. Support Care Cancer 25(5):1687–1698.  https://doi.org/10.1007/s00520-017-3614-y CrossRefPubMedGoogle Scholar
  31. 31.
    Farhangfar A, Makarewicz M, Ghosh S, Jha N, Scrimger R, Gramlich L, Baracos V (2014) Nutrition impact symptoms in a population cohort of head and neck cancer patients: multivariate regression analysis of symptoms on oral intake, weight loss and survival. Oral Oncol 50(9):877–883.  https://doi.org/10.1016/j.oraloncology.2014.06.009 CrossRefPubMedGoogle Scholar
  32. 32.
    Lango MN, Egleston B, Fang C, Burtness B, Galloway T, Liu J, Mehra R, Ebersole B, Moran K, Ridge JA (2014) Baseline health perceptions, dysphagia, and survival in patients with head and neck cancer. Cancer 120(6):840–847.  https://doi.org/10.1002/cncr.28482 CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Clinical Medicine, Faculty of MedicineUniversity of BergenBergenNorway
  2. 2.Department of Otolaryngology/Head and Neck SurgeryHaukeland University HospitalBergenNorway
  3. 3.Department of OtorhinolaryngologyOslo University Hospital-RikshospitaletOsloNorway
  4. 4.Faculty of HealthVID Specialized UniversityBergenNorway

Personalised recommendations